What Changed
Price Move History
- Daily moves over 5%
- 0 60 sessions, February 19, 2026 to November 4, 2026
- Largest daily move
- -2% close of June 4, 2026
Company Description
Paloma Acquisition I Units (NASDAQ: PALOU) is classified in the shell companies industry within the Financial Services sector.
PALOU has gained 0.1% over the past week. The last closing price was $10.11.
This page collects what Stock Titan holds for PALOU, including price data, latest news, SEC filings, and short interest trends.
Stock Performance
Paloma Acquisition I Units (PALOU) closed at $10.11 on November 4, 2026. Over the past week, the price has gained 0.1%.
PALOU Metrics & Rankings
Price returns through November 4, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Paloma Acquisition I Units has 3 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. Key topics include acquisition, IPO, offering. View all PALOU news →
SEC Filings
Paloma Acquisition I Units has filed 10 recent SEC filings, including 4 Form SCHEDULE 13G/A, 2 Form 10-Q, 2 Form SCHEDULE 13G, 1 Form 4. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all PALOU SEC filings →
Short Interest History
Short interest in Paloma Acquisition I Units (PALOU) currently stands at 10 shares. Since February 2026, short interest has decreased by 99.8%.
Days to Cover History
Days to cover for Paloma Acquisition I Units (PALOU) currently stands at 1.0 days, down 99.9% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.
PALOU Company Profile & Sector Positioning
Paloma Acquisition I Units (PALOU) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the NASDAQ.
Investors comparing PALOU often look at related companies in the same sector, including Drugs Made In America Acquisition II Corp. (DMII), EQV Ventures Acquisition Corp. II (EVAC), Bain Capital GSS Investment Corp. (BCSS), Cantor Equity Partners IV, Inc. (CEPF), and Churchill Capital Corp XII (CXII). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PALOU's relative position within its industry.